Treatment
and prevention of frailty; treatment of congestive
heart failure; treatment of catabolic illness (growth
hormone secretagogue).
Capromorelin Tartrate acts as a reagent used in the preparation of pyrazolopyridine amide growth hormone secretagogues for treatment of fibromyalgia
Capromorelin tartrate is a potent ghrelin receptor agonist/growth hormone secretagogue (Ki = 7 nM). In r at pituitary cells, Capromorlelin incudes growth hormone (GH) secretion with an EC50 of 3 nM. Capromorelin also increases gastric motility and has been studied recently in patients with spinal cord injuries.
